Patent · US Active

Anti-IL-17A/IL-17F cross-reactive antibodies

US8715669B2 · kind B2 · utility

23Cited by
55References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2011
Grant dateMay 6, 2014
Priority date—
Expiry dateMay 30, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL-17F homodimer, IL-17A, the IL-17A homodimer, and/or the heterodimeric IL-17A/IL-17F protein complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.